[Preprint] RECOVERY trial finds aspirin does not improve survival for patients hospitalized with COVID-19.
News Release: RECOVERY trial finds aspirin does not improve survival for patients hospitalised with COVID-19 – University of Oxford Original Study: Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial – medRxiv Commentary on Twitter (thread – click for more) RECOVERY Pre-print: Aspirin 14,892 patients randomised to aspirin […]
The post [Preprint] RECOVERY trial finds aspirin does not improve survival for patients hospitalized with COVID-19. appeared first on Links Medicus.
Review: Management of patients with venous thromboembolism after the initial treatment period.
Management of Patients With Venous Thromboembolism After the Initial Treatment Period – The Journal of the American Board of Family Medicine
The post Review: Management of patients with venous thromboembolism after the initial treatment period. appeared first on Links Medicus.
Synopsis | Updates to the Pediatrics Asthma Management Guidelines.
Updates to the Pediatrics Asthma Management Guidelines – JAMA Pediatrics (free for a limited period) Original Guideline: 2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group
The post Synopsis | Updates to the Pediatrics Asthma Management Guidelines. appeared first on Links Medicus.
Report: 376,000 people in UK have had long Covid symptoms for at least a year.
376,000 people in UK have had long Covid symptoms for at least a year – ONS – The Guardian Original report: Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK: 4 June 2021 – Office for National Statistics
The post Report: 376,000 people in UK have had long Covid symptoms for at least a year. appeared first on Links Medicus.
Multicenter Epidemiologic Study of Coronavirus Disease–Associated Mucormycosis, India – Uncontrolled diabetes mellitus was the most common underlying disease; improper glucocorticoid use was independently associated with the disease.
Multicenter Epidemiologic Study of Coronavirus Disease–Associated Mucormycosis, India – CDC Emerging Infectious Diseases Commentary: COVID19: Secondary Infections Still a Big Challenge in India – News Click Commentary on Twitter New study from India on mucormycosis – COVID-19 has led to increases in mucormycosis, partly from inappropriate steroid use – Uncontrolled diabetes was the most […]
The post Multicenter Epidemiologic Study of Coronavirus Disease–Associated Mucormycosis, India – Uncontrolled diabetes mellitus was the most common underlying disease; improper glucocorticoid use was independently associated with the disease. appeared first on Links Medicus.
The “Black Fungus” in India: The Emerging Syndemic of COVID-19–Associated Mucormycosis – careful use of antibiotics and corticosteroids and closely monitoring blood glucose levels are some of the strategies suggested by the authors.
The “Black Fungus” in India: The Emerging Syndemic of COVID-19–Associated Mucormycosis – Annals of Internal Medicine
The post The “Black Fungus” in India: The Emerging Syndemic of COVID-19–Associated Mucormycosis – careful use of antibiotics and corticosteroids and closely monitoring blood glucose levels are some of the strategies suggested by the authors. appeared first on Links Medicus.
Cohort study: long working hours (more than 55 h/week) linked to increased risk of recurrent coronary events.
Long Working Hours and Risk of Recurrent Coronary Events – Journal of the American College of Cardiology (link to abstract – $ for full-text) Commentaries: Working long hours may increase odds of second heart attack – American College of Cardiology AND Recurrent CHD Risk Up With Long Working Hours After First MI – HealthDay AND […]
The post Cohort study: long working hours (more than 55 h/week) linked to increased risk of recurrent coronary events. appeared first on Links Medicus.
Perspective | Could statins do more than lower cholesterol in patients with COVID-19? – “Don’t Start, Don’t Stop”.
Could Statins Do More Than Lower Cholesterol in Patients With COVID-19? – JAMA
The post Perspective | Could statins do more than lower cholesterol in patients with COVID-19? – “Don’t Start, Don’t Stop”. appeared first on Links Medicus.
Investigation | Covid 19: How harm reduction advocates and the tobacco industry capitalized on the pandemic to promote nicotine.
Covid 19: How harm reduction advocates and the tobacco industry capitalised on the pandemic to promote nicotine – The BMJ Commentaries: Researchers report how the tobacco and e-cigarette industry capitalized on COVID-19 to promote smoking – News Medical AND Investigation discredits studies suggesting lower COVID-19 risk for smokers
The post Investigation | Covid 19: How harm reduction advocates and the tobacco industry capitalized on the pandemic to promote nicotine. appeared first on Links Medicus.
2 new meta-analysis detail neurologic and psychiatric conditions in COVID-19.
Neurologic, psychiatric conditions common in COVID-19 – CIDRAP Meta-analysis 1: Neurology and neuropsychiatry of COVID-19: a systematic review and meta-analysis of the early literature reveals frequent CNS manifestations and key emerging narratives – Journal of Neurology, Neurosurgery & Psychiatry Meta-analysis 2: Central and peripheral nervous system involvement by COVID-19: a systematic review of the pathophysiology, […]
The post 2 new meta-analysis detail neurologic and psychiatric conditions in COVID-19. appeared first on Links Medicus.